Officers

Devyn Smith Headshot
Chair

Devyn Smith

CEO,
Arbor Biotechnologies
Bob Smith Headshot
Vice-Chair

Bob Smith

Former SVP, Global Gene Therapy Business,
Pfizer
Christopher Vann Headshot
Treasurer

Christopher Vann

SVP, COO,
Autolus Therapeutics
Kristin Yarema Headshot
Secretary

Kristin Yarema

President & CEO,
Poseida Therapeutics

Board of Directors

Faraz Ali

CEO,
Tenaya Therapeutics

Robert Ang

President & CEO,
Vor Biopharma

Catherine Bollard

Director of the Center for Cancer and Immunology Research,
Children's National Hospital and The George Washington University

Samuele Butera

President, Pulmonary Hypertension and Retina,
The Janssen Pharmaceutical Companies of Johnson & Johnson​

Amy Butler

President, Biosciences,
Thermo Fisher Scientific

Bradley Campbell

President & CEO,
Amicus Therapeutics

Moya Daniels

Chief Quality Officer,,
Diakonos Oncology

Lisa Deschamps

CEO & Executive Board Member​,
AviadoBio

Debbie Drane

SVP, Global Commercial Development,
CSL Behring

Miguel Forte

CEO,
Kiji Therapeutics

Audrey Greenberg

Co-Founder & CBO,
Center for Breakthrough Medicines

Matt Kapusta

CEO,
uniQure

Brett Kopelan

Executive Director,
Debra of America

Ann Lee

Chief Technology Officer,
Prime Medicine

Tim Lu

CEO,
Senti Biosciences

Anshul Mangal

President,
Project Farma/Precision ADVANCE​

John Maslowski

Chief Commercial Officer,
Forge Biologics

Chris Mason

Founder & Director,
Ori Biotech

Adora Ndu

Chief Regulatory Affairs Officer,
bridgebio

Susan Nichols

CEO,
Propel Biosciences

Karah Parschauer

Chief Legal Officer,
Ultragenyx

Kinnari Patel

President & Chief Operating Officer,
Rocket Pharma

Jacob Petersen

SVP, Head of Dicerna,
A Novo Nordisk Company

Louise Rodino-Klapac

Executive Vice President, Chief Scientific Officer,
Sarepta Therapeutics

Jeff Ross

President,
Miromatrix Medical, A United Therapeutics Company

Alberto Santagostino

SVP, Head of Cell & Gene Technologies Business Unit,
Lonza

Laura Sepp-Lorenzino

EVP & Chief Scientific Officer,
Intellia Therapeutics

Curran Simpson

Chief Operations and Technology Officer,
REGENXBIO

Bob Smith

Former SVP, Global Gene Therapy Business,
Pfizer

Devyn Smith

CEO,
Arbor Biotechnologies

Christopher Vann

SVP, COO,
Autolus Therapeutics

Kristin Yarema

President & CEO,
Poseida Therapeutics

Richard Wilson

SVP, Primary Focus Lead – Genetic Regulation,
Astellas

Executive Committee

Devyn Smith

CEO,
Arbor Biotechnologies

Bob Smith

Former SVP, Global Gene Therapy Business,
Pfizer

Christopher Vann

SVP, COO,
Autolus Therapeutics

Kristin Yarema

President & CEO,
Poseida Therapeutics

Miguel Forte

CEO,
Kiji Therapeutics

Laura Sepp-Lorenzino

EVP & Chief Scientific Officer,
Intellia Therapeutics

Adora Ndu

Chief Regulatory Affairs Officer,
bridgebio

Robert Ang

President & CEO,
Vor Biopharma